Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Conditions: Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8 Interventions: Drug: Cisplatin; Drug: Doxorubicin; Drug: Methotrexate; Biological: Pegfilgrastim; Biological: Pembrolizumab; Procedure: Radical Cystectomy; Drug: Vinblastine; Drug: Vinblastine Sulfate Sponsors: University of Washington; National Cancer Institute (NCI); Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials